Products for Research Use Only
RegisterLogin

Mito-LND (Mito-Lonidamine)

CAT: 0957-E5927-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0957-E5927-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Mito-LND (Mito-Lonidamine) is an orally administered mitochondria-targeted compound that inhibits oxidative phosphorylation (OXPHOS) . This agent reduces mitochondrial bioenergetics, promotes reactive oxygen species generation, and triggers autophagic cell death in lung cancer cells.
CAS Number
2361564-49-8
Synonyms
Mito-Lonidamine
Target
OXPHOS
Activity
Apoptosis
Molecular Formula
C43H45BrCl2N3OP

Related Products

CatalogName
S2610-01Lonidamine
S2610-100mgLonidamine
S2610-10mM/1mLLonidamine
S9733-5mgMito-TEMPO
S9733-01Mito-TEMPO
S9733-100mgMito-TEMPO
S9733-1gMito-TEMPO
S9733-25mgMito-TEMPO
S9733-10mM/1mLMito-TEMPO
S2610-25mgLonidamine

Alternative Products

CatalogName
C18321-5mgMito-LND (Mito-Lonidamine)
abx283374-01Mito-lonidamine (Mito-LND)
BA3620-1Mito-LND
TBI5492-5MGMito-lonidamine, Mitochondria-targeted antiglycolytic agent
C8299-1Mito-TRFS
BA6176-5.1Mito-TEMPO
HY-D2295Mito-FerroGreen
7641/1 PACKMito-HE
sc-301164Mito Red
P33969PDsRed1-Mito

Popular Products